Inpatient Smoking Cessation Counseling: Prevalence and Demographic Bias Among Patients Admitted with Acute Myocardial Infarction by Johnson, Jana
Inpatient Smoking Cessation Counseling: Prevalence and Demographic Bias Among 
Patients Admitted with Acute Myocardial Infarction 
By 
Jana Johnson 
A Master's Paper submitted to the faculty of 
The University ofNorth Carolina at Chapel Hill 
In partial fulfillment of the requirements for 
The degree of Master of Public Health in 
The Public Health Leadership Program. 
Chapel Hill 
2003 
Second Reader 
Date 
ABSTRACT 
BACKGROUND: Most studies of smoking cessation counseling have been done in 
outpatient settings and show that brief counseling can improve cessation rates. However, 
rates of counseling are low and vary based on patient demographics. Fewer studies 
addressing the delivery of smoking cessation counseling have been conducted in inpatient 
settings. Therefore, our research aims were: to assess the prevalence of cessation 
counseling delivered by providers to inpatient smokers admitted with AMI; to determine 
if a demographic bias exists as to who receives counseling; and to determine if an 
educational intervention for providers resulted in an increase in the frequency of smoking 
cessation counseling. 
METHODS: Medical Review of North Carolina conducted two prevalence studies of 
quality indicators, before and after an educational intervention for providers, among 
Medicare recipients who had been admitted with an acute myocardial infurction (AMI) in 
approximately 50 hospitals across the state. We performed a secondary data analysis of 
the smoking cessation counseling indicator from this project. 
RESULTS: 154 smokers were included in the Baseline study and 147 in the Follow up. 
Among the smokers, the median age was 68, 57% were male, and 82% were white. Prior 
to the intervention, 31% received cessation counseling, and after the intervention, 3 8% 
received counseling (p=0.16). Multivariate analysis revealed no demographic bias as to 
who receives counseling before the intervention, but revealed greater odds of receiving 
counseling for those who were male (OR 2.4, 95%CI 1.1-5.2) and lower odds of 
receiving counseling for those who were black (OR 0.3, 95%CI 0.08-0.8) after the 
intervention. 
CONCLUSION: The overall prevalence of smoking cessation counseling delivered to 
inpatient smokers with a smoking-related illness was low and the educational 
intervention did not increase it. However, after the intervention, a bias towards white 
males receiving counseling was demonstrated. Fntnre research needs to focus on 
effective strategies to increase rates of inpatient counseling and eliminate biases in 
delivery of that advice. In addition, studies need to be done to evaluate the effectiveness 
of brief inpatient cessation counseling. 
Cigarette smoking remains the number one preventable cause of death in 
this country1 In 2000, approximately 46.5 million adults (23.3%) in the United 
States were current smokers2 and during 1995-1999, more than 400,000 persons 
died prematurely each year as a result of smoking.3 The average annual cessation 
rate among smokers in 2000 was 4-6%. 2 
Although the highest smoking cessation rates are generally reported as a 
result of comprehensive smoking cessation programs (8-18% abstinence at 6 
months), studies in the outpatient setting have demonstrated that even brief 
smoking cessation counseling by a health care professional can result in a 2.5% 
absolute increase in cessation rates4 This translates into an additional 1.6 million 
smokers who could quit each year. In addition, the United States Preventive 
Services Task Force has given smoking cessation counseling an "A" 
recommendation for all persons who use tobacco products5 
These interventions have been documented in the literature primarily in 
the outpatient setting, and reveal a demographic bias as to who receives 
counseling. For example, a number of studies have demonstrated that whites are 
more likely to receive cessation counseling than blacks or non-white Hispanics. 
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16 Other studies have found that older subjects are more likely to be 
counseled 7'9-11 although a few studies associate younger age with a greater 
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smoking cessation counseling more often than men,9· 11 although 2 studies found 
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that younger women received counseling more often, while older men were more 
likely to receive smoking cessation counseling6 •7 
Other studies report a greater frequency of receiving advice to quit 
smoking among those who smoked more cigarettes per day, or had smoked for a 
greater number ofyears,5•6•8-12 and some studies report factors such as fair or poor 
self-reported health status, number of quit attempts and the presence of smoking-
related illnesses as associated with a greater frequency of receiving smoking 
cessation advice5 •8-11•13-15 Finally, several studies have specifically noted an 
association with a higher frequency of smoking cessation counseling and having 
cardiovascular disease or surviving an acute myocardial infarction (AMI). 6' 13-15 
In general, frequency of counseling in the outpatient setting varies from 48 to 
81%. 
Regarding smoking cessation counseling among inpatients, only one study 
has performed a demographic analysis in this setting specifically addressing who 
receives counseling, but it was underpowered to find any effects. 17 Another study 
noted that hospital staff were much more likely to counsel patients hospitalized on 
a cardiovascular disease unit than on a general medical unit, 18 which is consistent 
with other data suggesting that patients with more severe illness are more likely to 
receive smoking cessation counseling. 
Studies evaluating the efficacy of hospital-based smoking interventions 
have shown mixed results, although types of interventions and results vary 
widely. 19-26 For example, in a review of smoking cessation interventions in 
hospitalized patients, France, et a! found that only 1 of 5 studies evaluating low to 
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moderate intensity hospital interventions demonstrated an improvement in long-
term quit rates27 However, the positive study was published in 1974 and lacked 
detailed data regarding success of implementation of physician advice or follow-
up clinic or home visits28 The other studies lacked sufficient power to detect 
meaningful increases in cessation rates. 
Another review of interventions for smoking cessation in hospitalized 
patients concluded that post-discharge follow-up after inpatient smoking cessation 
interventions increased abstinence rates22 That review found no studies 
reporting on the efficacy of brief advice during hospitalization with no subsequent 
follow-up. 
Recently, however, Hajek, et al25 published results of a randomized 
controlled trial evaluating a brief, single session smoking cessation intervention 
among inpatients who had had an AMI and bypass surgery in 17 hospitals in 
England. This study found no difference in abstinence rates at 12 months 
between intervention and control groups. The authors concluded that a single 
session intervention is likely not enough to reach a highly dependent group of 
smokers as those in this study. Of note, the smoking cessation intervention in this 
study was delivered by existing cardiac rehabilitation nurses with no special 
training in counseling or behavioral interventions. This also may have played a 
role in the negative findings, as another recent study29 has suggested smoking 
cessation interventions for hospitalized patients may be more effective when 
delivered by trained counselors. 
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In general, studies of inpatient smoking cessation interventions have 
shown mixed results and have lacked consistency of study design, type of 
intervention, and type and degree of follow-up. In spite of these discrepancies, 
many health care professionals agree that undertaking smoking cessation 
counseling with smokers who have been admitted to the hospital, particularly with 
a smoking-related illness, is especially advantageous because many such patients 
may be more willing to quit at that time. Hospitalization of these smokers is a 
"teachable moment", likely to increase perceived vulnerability to smoking-related 
health harms and responsiveness to medical quit-smoking advice21 In fact, 
Sciammana, et af6 found that smoking behavior in the first 24 hours of 
hospitalization predicts long-term remission, suggesting that smoking cessation 
counseling and interventions during admission may improve quit rates. 
Interestingly, hospitalization itself has been shown to be associated with 
smoking cessation, with long-term quit rates following hospitalization tending to 
be higher than those of the general population. Further, quit rates among patients 
admitted to a coronary care unit are higher than those of other hospitalized 
patients, even in the absence of smoking cessation interventions27 
Although current evidence regarding the efficacy of inpatient smoking 
cessation counseling is inconclusive, many reasons exist to suggest that delivering 
cessation advice in this setting may be useful. For example, solid evidence in the 
outpatient setting that brief counseling is effective, the abstinence required by 
hospitals among inpatients, and the "teachable moment" that admission due to a 
smoking-related illness provides are all compelling incentives to take advantage 
4 
of this counseling opportunity. For the purposes of this study, we will assume 
that brief, inpatient smoking cessation counseling delivered by existing hospital 
staff is an effective tool that increases abstinence rates. 
Given the paucity of data regarding patient characteristics associated with 
receiving smoking cessation counseling in inpatients compared to that of 
outpatients and the potential to improve cessation rates in hospitalized patients by 
taking advantage of the "teachable moment", we undertook this secondary data 
analysis to answer the following questions: I) What is the proportion of cardiac 
inpatients in small to mid-sized rural hospitals that receive smoking cessation 
counseling? 2) Does a demographic bias exist among hospitalized patients as to 
who receives smoking cessation counseling? 3) Do patients with more 
comorbidities receive smoking cessation counseling more often than those with 
fewer comorbidities? 4) If a demographic bias does exist among smokers as to 
who receives cessation counseling, does a simple smoking cessation intervention 
eliminate the bias? 5) Does a simple, inexpensive smoking cessation intervention 
increase the proportion of cardiac inpatients that receive smoking cessation 
counseling? 
Methods 
The Medical Review ofNorth Carolina (MRNC), the Quality 
Improvement Organization (QIO) for the state, performed serial prevalence 
studies of 1478 charts ofMedicare patients admitted with a diagnosis of acute 
myocardial infarction (AMI). This study, the National AMI Medicare Quality 
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Improvement Project, was developed with the objective of decreasing mortality 
rates from AMI among Medicare beneficiaries. To this end, the project aimed to 
increase compliance with the following quality indicators that the literature has 
suggested are associated with improved outcomes: Aspirin administered during 
the hospital stay, aspirin prescribed at discharge from the hospital, beta-blocker 
prescribed at discharge, ACE inhibitor prescribed at discharge, and smoking 
cessation advice given during hospitalization. 
This study analyzes results regarding only the smoking cessation advice 
indicator. Therefore, data for this study was from Medicare enrollees who were 
current smokers and were admitted with a principal diagnosis of AMI to 
approximately 50 hospitals across North Carolina that were part of the National 
AMI Medicare Quality Improvement Project. Most hospitals in this analysis were 
in rural communities and had less than 300 beds. One large academic medical 
center participated in the study. The participating hospitals were comprised of a 
convenient sample of all hospitals in North Carolina that collaborate with MRNC. 
The first round of data collection ("Baseline") in this serial prevalence 
analysis included information gathered from 731 eligible patients between 
October 1, 1998 and March 31, 1999, which was followed by a smoking cessation 
counseling intervention. After the intervention, described below, a second round 
of data ("Follow-up") was collected from 747 different eligible patients between 
January 1, 2001 and June 30, 2001. 
Data for 4 variables (whether patient was a current smoker, whether 
patient had documentation of smoking cessation advice, discharge date, date of 
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birth) were abstracted from the charts of eligible patients. Smoking status as 
abstracted from the patient chart was used to determine whether the patient was a 
smoker for the purposes of this study. The formal ICD-9 diagnosis of Tobacco 
Use Disorder, if present, was given to patients at discharge and was considered a 
"secondary diagnosis". It was not used to determine smoking status as eligibility 
for this study. A full description of data abstraction methods is described 
elsewhere. 30 
Age was calculated from date of birth and date of discharge. Data for the 
other variables in this analysis (sex, secondary diagnoses, race, and discharge 
disposition) were collected from the National Claims History database for the 
same patients over the same time periods. The number of comorbidities and 
diagnoses (other than AMI) were calculated from the "secondary diagnosis" 
variable. 
The intervention, called the Smoking Cessation Toolkit, was developed by 
MRNC for the hospitals in the study. Instructions for the interventions were 
delivered to hospitals via a teleconference on September 26, 2000. Participants in 
the teleconference included 3 physicians with expertise in smoking cessation 
and/or cardiology, the project coordinator from MRNC, and at least one 
representative from each of the participating hospitals. The content of the call 
included descriptions of the quality indicators from the National AMI Medicare 
Quality Improvement Project, a presentation describing the importance of 
smoking cessation counseling in patients who have had an AMI, and a 
presentation reviewing the Public Health Service smoking cessation guidelines. 
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Subsequently, the presenters discussed the contents of the Smoking 
Cessation Toolkit, which contained notes for the teleconference presentations, a 
review of the Quality Improvement Project, a journal article overview of the 
Clinical Practice Guideline for Treating Tobacco Use and Dependence,31 
strategies for implementing the Guideline, sample documents for hospitals to use 
in implementing the intervention, resources for information regarding heart 
disease, AMI or smoking cessation, a Smoker Identification Chart Sticker and 
Smoking Cessation Documentation Label, and a Patient Education Kit. Each 
hospital was then responsible for ordering these materials free of charge and 
implementing the counseling intervention. Evidence from order forms suggests 
that the majority (approximately 80%) of participating hospitals ordered at least 
some of the available materials. 
The intervention instructions delivered to the participating hospitals called 
for the admitting nurse to determine the smoking status of the patient and place a 
yellow Smoking Identification Sticker on the chart to remind providers to deliver 
smoking cessation counseling. The instructions then outlined a plan calling for a 
health care provider to deliver the Patient Education Kit to the patient, discuss 
with them briefly the importance of smoking cessation, and answer any questions 
the patients might have, immediately prior to discharge. Once this was done, the 
instructions indicated that the provider should place the Smoking Cessation 
Documentation Label and the Patient Education Label on the patient's chart and 
sign them, to document smoking cessation counseling and delivery of smoking 
cessation education had occurred, respectively. 
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Statistical Analysis 
All analyses were performed using Stata Version 8.0 statistical software 
(Stata Corp., College Station, TX). 
Only data from smokers in the Baseline group (n=l54) and in the Follow-
up group (n=l47) were used in this analysis. Pearson's x2 test was used in the 
bivariate analysis to assess the association between frequency of smoking 
cessation counseling and variables likely to be related to counseling. These 
variables were chosen based on data from smoking cessation literature suggesting 
an association of these factors with receiving advice to quit smoking. They 
include age, race, sex, number of comorbidities, discharge disposition, and 
diagnosis. 
To control for confounding, variables that demonstrated a statistically 
significant association with smoking cessation counseling in the bivariate 
analysis, along with others thought to be strongly associated with smoking 
cessation counseling, were included as independent variables in a multiple logistic 
regression model, with smoking cessation counseling as the dependent variable. 
Variables not statistically significantly related to smoking cessation counseling 
were assessed with the Wald test to ensure that they could be dropped from the 
logistic regression model. 
Dummy variables were created for age ( <=68 years and >68 years), for 
number of comorbidities (<=3 and >3), and for race (Black, White, Other). 
Because so few subjects were in the "Other'' or Native American categories for 
race (3 in Baseline, 2 in Follow up), these observations were not used in the 
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analysis. Data for the Race variable were missing for 7 subjects in the Baseline 
group, therefore, analyses were performed with the Race data that existed for the 
other subjects. The subjects with missing Race values had data for all of the other 
variables and were included in all other analyses. 
Results 
Frequency Data 
Frequency data for Baseline and Follow-up groups (Table 1) demonstrated 
an even distribution of patients older and younger than 68 years. A majority of 
these patients, however, were white (83% Baseline, 82% Follow-up) and male 
(68% Baseline, 57% Follow-up). A higher frequency was discharged to home 
(68% Baseline, 61% Follow-up) compared to other discharge dispositions (32% 
Baseline, 39% Follow-up) and the majority of patients had a documented 
diagnosis of coronary artery disease (57% Baseline, 65% Follow-up). A 
relatively even distribution of other diagnoses was seen with the exception of a 
slight predominance of tobacco use disorder and hypertension. 
What is the Prevalence of Smoking Cessation Counseling? 
Overall, 31% of smokers in the Baseline group had documentation of 
smoking cessation counseling in their chart. 
Does a Demographic Bias Exist As To Who Receives Counseling? 
Bivariate analysis of the Baseline group (Table 2) demonstrated 
statistically significant associations between patients' receiving smoking cessation 
counseling and having a diagnosis of tobacco use disorder documented in their 
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charts (p<0.001), as well as with being discharged to home (p=0.02). Patients 
older than 68 years tended to receive counseling more often than patients less than 
68 years. Those with documented diagnoses of coronary artery disease and 
hyperlipidemia tended to receive counseling more often than patients without 
those diagnoses. 
Multiple logistic regression analysis ofBaseline group data (Table 3) 
revealed greater odds of receiving smoking cessation counseling for those patients 
with a formal ICD-9 diagnosis of Tobacco Use Disorder documented in their 
charts as compared to those without such documentation (OR4.7, 95% CI 2.1-
10.4 ), and if they were discharged to home as compared to other discharge 
dispositions (OR2.7, 95%CI 1.1-7.0), controlling for the presence of coronary 
artery disease (CAD) and hyperlipidemia. 
Do Patients With More Comorbidities Receive Counseling More Often? 
The majority of patients in both the Baseline and Follow-up groups had 
more than 3 comorbidities (86%, 89%, respectively). Bivariate analysis in neither 
the Baseline nor the Follow-up groups revealed an association between number of 
comorbidities and receiving smoking cessation counseling. 
Does a Simple Intervention Eliminate Bias? 
Bivariate analysis of Follow-up data (Table 4) demonstrated statistically 
significant associations between receiving smoking cessation counseling and 
having a formal diagnosis of Tobacco Use Disorder documented in the chart 
(0.02), black race (p=0.03), female sex (p=0.006), and being discharged to home 
(p=0.002). An association was noted between patients with diagnoses of CAD 
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and congestive heart failure ( CHF) and receiving counseling compared to those 
without such diagnoses, but this did not reach statistical significance. 
Multiple logistic regression analysis ofFollow-up data (Table 5) 
demonstrated greater odds of receiving smoking cessation counseling for those 
with a formal diagnosis of Tobacco Use Disorder documented in their charts as 
compared to those without this diagnosis (OR 3.4, 95%CI 1.4-7.6) and for those 
who were male (OR 2.4, 95%CI 1.1-5.2). Patients had lower odds of receiving 
counseling if they were black (OR 0.3, 95%CI 0.08-0.8). 
Does a Simple Intervention Increase Counseling Frequency? 
Overall, 38% of smokers in the Follow-up group had documentation of 
smoking cessation counseling in their chart. Chi-square analysis comparing this 
to the baseline frequency of counseling (31%) was not statistically significant 
(p=0.16). 
Discussion 
What is the Prevalence of Smoking Cessation Counseling? 
The overall frequencies of smoking cessation counseling in this study are 
consistent with those from the literature in both inpatient and outpatient 
populations that demonstrate that the great majority of smokers with smoking-
related illnesses are not being counseled to quit smoking. Among patients 
admitted with an acute myocardial infarction, only 31% of smokers in the 
Baseline group and 38% in the Follow-up group were counseled for smoking 
cessation. Health care providers are failing to document smoking cessation 
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counseling with over 60% of smokers admitted with AMI. This is perhaps the 
most striking feature of this study. Physicians and other health care providers are 
missing a valuable opportunity (the "teachable moment") to inform, educate and 
advise a population of smokers who have already suffered health consequences 
related to smoking about the benefits and methods of quitting. 
In this study, no control group of smokers admitted with a non-smoking-
related illness was included in the analysis. Anda, et al6 demonstrated a higher 
likelihood of cessation counseling among patients who survived an AMI, and 
other studies have shown a similar association among patients with a history of 
cardiovascular disease. 10•13-15 Therefore, smoking cessation frequencies among 
hospitalized smokers with non-smoking-related illnesses may be even lower than 
those reported in this study among smokers who were AMI survivors. 
As with any intervention, the frequency of the delivery of inpatient 
smoking cessation counseling is most important if it improves the outcome of 
interest, in this case long-term abstinence rates. However, the literature is 
inconsistent regarding long-term abstinence rates as a result of brief hospital-
based smoking cessation interventions. Several studies show increased long-term 
abstinence rates as a result of inpatient smoking cessation interventions, but levels 
of intensity of interventions and degree of post-discharge follow-up vary 
markedly21•26•33'35 Other studies show no effect of hospital-based cessation 
interventions and, as with positive studies, report on widely varying types of 
cessation programs. 19•20•24•29 A recent systematic review of interventions for 
smoking cessation in hospitalized patients found that high-intensity interventions 
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with 1 month offollow-up improved cessation rates, but insufficient evidence 
existed to assess the effect of very brief interventions delivered during the hospital 
stay. 36 These inconsistencies limit the ability to draw useful conclusions from the 
data, and prevent analysis of the efficacy of individual components of each 
intervention. 
No study has evaluated the efficacy of an intervention such as the one in 
this study, although Hajek, et al25 suggested in a recent controlled trial that this 
type of brief intervention is not useful in patients admitted after an AMI. 
However, given the lack of conclusive data regarding the efficacy of brief 
hospital-based smoking cessation interventions, the smoke-free environment of 
hospitals today that requires abstinence during admission thus providing a "quit 
date", and good outpatient data suggesting brief smoking cessation advice 
improves quit rates, the delivery of smoking cessation counseling to inpatients 
can, at the very least, raise awareness of the importance of quitting and educate 
patients about various quitting methods (nicotine replacement therapy, bupropion, 
outpatient programs, etc.). Inpatient smoking cessation counseling may also 
improve abstinence rates. Health care providers must take advantage of this 
prime opportunity to intervene among this population of smokers. 
This intervention is particularly important in the elderly because they are 
at higher risk for smoking-related illnesses, and studies have documented the 
benefit of smoking cessation in those over age 65. For example, Jajich, et al37 
demonstrated that the effects of smoking are at least partially reversible within 1 
to 5 years after quitting even among older persons (age 65-74 years) who have 
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smoked for decades. Active smokers in that study had an excess risk of coronary 
heart disease death of75% compared with those who had quit, and the mortality 
rates for ex-smokers were no higher than for nonsmokers. In addition, 
Hermanson, et al38 studied the effects of smoking and cessation in a cohort from 
the Coronary Artery Surgery Study (CASS) and saw no diminution of beneficial 
effect of smoking cessation with increasing age. Smoking cessation lessened the 
risk of death or AMI in older and younger patients with CAD in that study. 
Does a Demographic Bias Exist As To Who Receives Counseling? 
At baseline, bivariate and multivariate analyses did not demonstrate a 
demographic bias with respect to who receives smoking cessation counseling, 
although we found an association between having tobacco use disorder 
documented in the chart and receiving advice to quit smoking. However, 
diagnoses in this study were those that were documented in the chart using formal 
ICD-9 codes at the time of hospital discharge. As a result, the association 
between the diagnosis of tobacco use disorder in the chart and the receipt of 
smoking cessation counseling may represent the fact that those physicians who 
performed smoking cessation counseling may have been more likely to give the 
patient a formal diagnosis of Tobacco Use Disorder at discharge, rather than 
representing a higher likelihood of receiving counseling as a result of already 
having that diagnosis on the chart at admission. We have no data indicating the 
number of patients who were admitted with a formal ICD-9 diagnosis of Tobacco 
Use Disorder in the chart, and we have no data regarding the number of charts 
that received stickers indicating the smoking status of patients after the 
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intervention, so analysis of this association is not possible in this study. Studies in 
outpatients, however, have documented that physicians are more likely to provide 
cessation advice when patients' smoking status is routinely identified in the 
medical recordi1'32 
Surprisingly, in this analysis, only approximately 40% of smokers in each 
group had formal ICD-9 code documentation of Tobacco Use Disorder in their 
charts, and only SO% of those patients in each group were counseled. This 
suggests that even formal documentation in the chart of this ICD-9 diagnosis did 
not provide a strong enough incentive for providers to deliver cessation 
counseling in half of smokers for whom they entered this diagnosis. The factor(s) 
contributing to the lack of cessation counseling of smokers in this setting is( are) 
unclear. 
Patients who were discharged to home were associated with a higher 
frequency of receiving smoking cessation counseling in both the bivariate and 
multivariate analyses. One possible explanation for this is that those patients well 
enough to go home after hospitalization may have seemed more receptive to 
smoking cessation counseling, more interactive in discussion about quitting, and 
more likely to heed advice to quit. Although no association was seen between 
number of comorbidities and smoking cessation counseling, those patients who 
were discharged to home may also have been healthier. 
Do Patients With More Comorbidities Receive Counseling More Often? 
Our analysis did not demonstrate an association between the number of 
comorbidities and the frequency of receiving smoking cessation counseling. The 
16 
literature suggests, however, that patients with more comorbidities, especially 
when the comorbidities are smoking-related illnesses, are more likely to receive 
smoking cessation advice.13' 15' 18 The likely explanation for the lack of 
association in this study is the small sample size and the fact that more than 80% 
of patients in the Baseline and the Follow-up groups had greater than 3 
comorbidities. 
Does a Simple Intervention Eliminate Bias? 
Follow-up data revealed more statistically significant predictors of 
smoking cessation counseling than did Baseline data. This is surprising because 
we expected the intervention to result in more uniform counseling of all inpatient 
smokers in this study. A possible explanation for this is that the intervention 
raised awareness among health care providers so that they initiated counseling 
more often, but without a specific effort to counsel all patients uniformly. The 
lower odds of black patients receiving smoking cessation counseling is consistent 
with results from outpatient studies,7'10"12 while the finding that males received 
counseling more often than females contributes to the mixed findings of various 
studies, although most show higher frequencies of counseling for females7•9-11 
than for males. 12 
Does a Simple Intervention Increase Counseling Frequency? 
We found no statistically significant increase in the frequency of the 
delivery of smoking cessation counseling as a result of this intervention. Because 
we have no data as to how many hospitals implemented the intervention, we 
cannot determine whether the lack of an increase in counseling frequency is 
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because the intervention failed or because it was not implemented by all of the 
hospitals. 
Limitations 
This study has several limitations. First, all results are from reviews of 
charts and an administrative database (National Claims History) and therefore rely 
on accurate documentation by health care providers of all variables collected. 
Providers likely underdocument the occurrence of smoking cessation counseling17 
along with other patient information resulting in inaccuracies in analysis results. 
However, although the low frequencies of smoking cessation counseling in this 
study are possibly due in part to underdocumentation, this is unlikely to account 
for the entire gap between those who smoked and those who received cessation 
advice. As mentioned, only 40% of smokers in each analysis group had a formal 
ICD-9 diagnosis of Tobacco Use Disorder documented in their charts. This type 
of underreporting likely occurred with other variables as well. 
Second, the Follow-up group of patients was comprised of different 
individuals than patients in the Baseline group. Although all patients were 
Medicare enrollees admitted with a diagnosis of AMI and general characteristics 
were similar between groups, the assessment of different individuals in the 
Follow-up group allows for other variables among patients that may have affected 
their likelihood of receiving counseling, i.e. they may have seemed more or less 
receptive to smoking cessation advice, etc. 
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Third, no data were collected with respect to other factors that the 
literature suggests are often associated with smoking cessation counseling. These 
factors include race and gender of the health care provider, and other patient 
characteristics such as socioeconomic status, level of education, degree of 
readiness to quit, number of cigarettes smoked, duration of smoking, or degree of 
nicotine dependence. These variables may have confounded results as to who 
received smoking cessation counseling in this analysis. 
Fourth, of all the Medicare patients involved in the National AMI 
Medicare Quality Improvement Project, only 20% (154 patients in the Baseline 
group and 147 patients in the Follow-up group)(Table 1) were smokers. As a 
result, the study was likely underpowered to detect other effects noted in the 
literature as relating to smoking cessation counseling. This percentage is 
somewhat higher than population figures reported by the CDC, which listed the 
smoking prevalence for Americans over age 65 as 9. 7%3 This difference is likely 
because this cohort was selected due to the presence of a smoking-related illness 
(AMI) and therefore represents a larger proportion of smokers. Even so, the low 
absolute numbers of patients in this study could have resulted in an absence of 
effects for some variables such as number of comorbidities, CAD, hyperlipidemia 
and age that may have been detected with larger sample sizes. 
Finally, because we have no standardized method of measuring which 
hospitals implemented the intervention, and to what degree it was implemented, 
we have no way of determining how these differences may have influenced the 
results. The intervention may have been more effective if hospitals had more 
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rigorously implemented it, or the results may represent its maximal efficacy if all 
of the hospitals implemented it fully. If long-term abstinence data had been 
collected after the intervention, we may have been able to determine if the 
counseling that was done was effective, and if the increase in counseling 
frequencies from 31% to 38% (Baseline and Follow-up, respectively) was 
clinically, if not statistically, significant. 
A particular advantage of this analysis of the National AM1 Quality 
Improvement Project, however, is the fact that the intervention was implemented 
in mostly rural, community hospitals. Therefore, these data have good external 
validity and may reflect what is feasible in similar hospital settings across the 
country. 
Future Efforts 
Improving the frequency of smoking cessation counseling among 
inpatients requires a change in health care provider behavior. Numerous studies 
have assessed the methods and efficacy of changing physician behavior, and a 
recent review of this literature concluded that "imperfect" evidence exists to 
determine which implementation strategies are most effective39 
However, a review of randomized controlled trials that evaluated the 
efficacy of continuing medical education lists several characteristics of 
interventions that were associated with significant changes in various physician 
behaviors40 Among these characteristics were two-way communication between 
participants, printed and graphic materials in person, and the presence of locally 
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respected health personnel who served as medical educators. Investigators of the 
trials in the review were interviewed and their feedback suggested that orienting 
provider's efforts around a public health approach to clinical practice, giving 
physicians feedback on behaviors, and looking at clinical outcomes of 
interventions to assure that strategies improve patient's health were factors that 
would improve efforts at health care provider behavior change. Finally, the study 
concluded that high priority should be given to the recruitment of medical 
educators, that interventions of the greatest value would be transferable to 
different settings, and that researchers must be vigilant in following up positive 
physician behaviors to determine the need for reinforcement. 
These qualities of effective continuing medical education strategies can be 
applied to interventions to improve smoking cessation counseling among 
inpatients. For example, an effective intervention to improve the frequency of 
smoking cessation counseling in this population may resemble the following 
scenario: Members oflocal health departments who are known and respected by 
health care providers and who are trained in smoking cessation counseling 
techniques could provide smoking cessation counseling training for providers at 
the local hospital, using one-on-one or small group communication as well as 
printed and graphic materials. This would take advantage of data that suggest that 
the most effective inpatient cessation interventions are delivered by providers 
trained in smoking cessation counseling29 Medical educators could provide 
feedback during training using role-playing. 
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A prospective cohort study could be used to assess the effectiveness of 
smoking cessation counseling on quit rates. However, during the study, the 
baseline prevalence of smoking cessation counseling could also be determined 
among this cohort of smokers, followed by providers implementing the training 
they had received. Medical educators could then provide effectiveness feedback 
through the measurement of the frequency of smoking cessation counseling at 
some point after the intervention had begun. In addition, the prevalence of 
cessation counseling could be determined among various demographic groups to 
assess the presence of bias regarding who received counseling. 
Finally, long-term (12 month) abstinence rates could be collected and 
analyzed for everyone in this cohort of smokers (both counseled and not 
counseled) admitted during a specified time period to determine the effectiveness 
of the counseling intervention on quit rates. 
As a result of this project, providers would receive important training 
regarding smoking cessation counseling, researchers would be able to determine 
the effectiveness of the intervention on counseling frequencies, and researchers 
and providers could collect data regarding demographic biases among those 
counseled, as well as determine the effectiveness of the intervention on patient 
outcomes (12 month abstinence rates). In addition, because the project would be 
locally supervised, researchers could easily follow-up physician behavior to 
determine the need for reinforcement. 
Undoubtedly, a randomized controlled trial of this intervention would 
provide more accurate data regarding its effectiveness at increasing abstinence 
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rates, and this could also be performed. However, the cohort study described 
above allows for the determination of the effectiveness of the intervention at 
increasing cessation rates as well as of counseling prevalence before and after the 
intervention, a measurement that would not be possible in a randomized 
controlled triaL This information would be valuable in assessing the project's 
effectiveness at changing physician behavior. 
Other changes that would likely increase the frequency of smoking 
cessation counseling by providers among inpatients include Medicare, Medicaid 
and private insurance reimbursement of cessation counseling as well as rigorous 
assessment of inpatient cessation counseling frequencies by Quality Improvement 
Organizations across the country with prevalence feedback provided to each 
hospitaL 
This study implies that most smokers with smoking-related illnesses are 
not being counseled to quit, and suggests that white males may receive counseling 
more often than other groups. Inpatient trials are needed to assess biases that may 
be associated with the delivery of smoking cessation advice and to provide the 
stimulus to assure that all smokers receive cessation counseling. Future research 
must also attempt to identify health care provider education programs that 
effectively and positively change provider cessation counseling behavior and 
must conclusively determine the efficacy of brief, hospital-based smoking 
cessation interventions. Research studies with sufficient sample sizes to detect 
small effects are needed to determine if existing hospital staff, trained by public 
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health medical educators, can effectively deliver useful inpatient smoking 
cessation advice that results in long-term abstinence. 
I 
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Table I. Frequency Data of Baseline and Follow-up groups. 
Baseline Follow-up 
Characteristic Total(%) Total(%) 
(n=154) (n=147) 
Age (yrs) 
>=68 51 54 
<68 49 46 
Race (n=l44) (n=l45) 
White 83 82 
Black 17 18 
Sex 
Male 68 57 
Female 32 43 
Discharge Status 
Home 68 61 
Other* 32 39 
Diagnosis** 
CAD 57 65 
Hyperlipidemia 10 22 
Tobacco Use 41 43 
COPD 25 31 
HTN 35 49 
AF 16 14 
CHF 30 32 
Mitral Valve d/o 11 10 
Number of 
Comorbidities 
<=3 14 11 
>3 86 89 
*Other= Discharge to Other Hospital, Skilled Nursiug Facility, 
Intenuediate Care Facility, Another Institution, Home Health 
Services, or Left Agaiust Medical Advice. 
** CAD = corouary artery disease; COPD = chronic obstructive 
pulmonary disease; HTN = hypertension; AF = atrial fibrillation; 
CHF = congestive heart failure 
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Table 2. Baseline Data. Frequencies of Patient Characteristics and Results of x2 Analyses 
of Associations of Patient Characteristics With Receiving Smokiog Cessation Couoseliog. 
Total(%) (%) (%) Not 
·l 
Characteristic (n=154) Counseled Counseled p value 
(u = 47) (n=107) 
Age (yrs) 
>=68 51 40 56 0.07 
Race (n=144) (n=44) (n=IOO) 
White 83 89 81 0.26 
Black 17 11 19 
Sex 
Male 68 64 69 0.52 
Female 32 36 31 
Discharge Status 
Home 68 83 64 0.02 
Other* 32 17 36 
Diagnosis** 
CAD 57 68 51 0.07 
Hyperlipidemia 10 17 7 0.07 
Tobacco Use 41 68 29 <0.001 
COPD 25 19 27 0.29 
HTN 35 36 35 0.85 
AF 16 13 18 0.44 
CHF 30 26 32 0.57 
Mitral Valve 11 6 13 0.28 
d/o 
Number of 
Comorbidities 
>3 86 87 85 0.72 
*Other~ Discharge to Other Hospital, Skilled Nursiog Facility, Another Institution, Home Health 
Services, or Left Against Medical Advice. 
** CAD~ coronary artery disease; COPD ~ clnonic obstructive pulmonary disease; HTN ~ 
hypertension; AF ~ atrial fibrillation; CHF ~ congestive heart failure 
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Table 3. Logistic Regression of Statistically or Clinically Significant 
Factors Associated Witb Receiving Smoking Cessation Counseling, 
Baseline Group. 
Characteristic OR 95%CI 
Tobacco Use Disorder 4.7 2.1, 10.4 
Discharge to Home 2.7 1.1, 7.0 
CAD 1.2 0.5, 2.8 
Hyperlipidemia 2.3 0.7, 7.7 
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Table 4. Follow-up Data. Frequeocies of Patient Characteristics and Results of l Analyses 
of Associations of Patient Cbaracteristics Witb Receiving Smoking Cessation Counseliog. 
Total(%) (%) (%)Not xz 
Characteristic (n=147) Counseled Counseled p value 
(n=56) (n=91) 
Age (yrs) 
>=68 54 46 58 0.16 
Race (n=l45) (n=89) 
White 82 91 76 0.03 
Black 18 9 24 
Sex 
Male 57 71 48 0.006 
Female 43 29 52 
Discharge Status 
Home 61 77 51 0.002 
Other* 39 23 49 
Diagnosis** 
CAD 65 73 59 0.08 
Hyperlipidemia 22 27 20 0.42 
Tobacco Use 43 55 35 0.02 
COPD 31 29 32 0.67 
HTN 49 45 52 0.41 
AF 14 18 11 0.24 
CHF 32 23 37 0.07 
Mitral Valve 10 7 11 0.44 
d/o 
Number of 
Comorbidities 
>3 89 86 91 0.29 
*Other= Discbarge to Other Hospital, Skilled Nursing Facility, Intermediate Care Facility, 
Anotber Institution, Home Healtb Services, or Left Against Medical Advice. 
** CAD= coronary artery disease; COPD = cbronic obstructive pulmonary disease; HTN = 
hypertension; AF = atrial fibrillation; CHF = congestive heart failure 
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Table 5. Logistic Regression of Statistically or Clinically Significaot 
Factors Associated With Receiving Smoking Cessation Counseling, 
Follow-up Group. 
Characteristic OR 95%CI 
Tobacco Use Disorder 3.4 1.4, 7.6 
Sex (Male) 2.4 1.1, 5.2 
Race (Black) 0.3 0.08, 0.8 
Discharge to Home 1.4 0.5, 3.8 
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